NEW YORK (GenomeWeb) – The China Food and Drug Administration has approved Agilent Technologies' SureScan Dx microarray scanner for in vitro diagnostic use, the company announced today. 

The scanner is also CE marked for in vitro diagnostic use in Europe and approved for in vitro diagnostic use in South Korea and Singapore. It measures fluorescence signals from labeled DNA and RNA targets hybridized to microarrays, for example, to compare DNA samples, Agilent said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.